← Leaderboards
David M. Underhill
Institute For Systems Biology
$23,556,171
Attributed
$28,911,839
Total exposure
14
Grants
11
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $3.5M · FY2005–25$5M$3.8M$2.5M$1.3M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$28,911,839 · 14
By mechanism
R01$25,109,816 · 8
P01$2,173,223 · 1
R21$1,328,800 · 3
R56$300,000 · 1
U54$0 · 1
Top collaborators
- George Y Liu7 shared
- Gislaine A Martins5 shared
- Rohan Dharmakumar4 shared
- Gil Y Melmed4 shared
- Philip Kent Frykman2 shared
Others in their field
Top investigators on “Inflammatory Response”
- Constance Ann Benson · University Of California, San Diego$65,790,143
- Donald Ym Leung · University Of Colorado Denver$45,344,508
- Charles Nicholas Serhan · Brigham And Women'S Hospital$37,745,494
- Asrar B. Malik · University Of Illinois At Chicago$36,954,043
- Ronald Gary Tompkins · Massachusetts General Hospital$36,214,797
- Rosalind J Wright · Icahn School Of Medicine At Mount Sinai$35,277,103
Research focus
Inflammatory ResponseImmune ResponseMacrophageInflammatoryMediatingReceptorInflammationIn VitroIn VivoDendritic CellsCellsImmuneFungusCytokineDectin 1PhagocytesResponseSignal TransductionLinkHost DefenseAntifungal AgentsGenesImmunologic ReceptorsSignal Pathway
Grant awards (68)
Malassezia Immune Responses as Biomarkers of IBD$680,687
R01 · FY2025 · DK · contact PI
Targeting the Mycobiome in Genetically Defined Patients with Crohns Disease$548,343
R01 · FY2025 · DK · contact PI
PD-L1 Signaling in Phagosomes$300,000
R56 · FY2025 · AI · contact PI
Targeting the Mycobiome in Genetically Defined Patients with Crohns Disease$633,061
R01 · FY2023 · DK · contact PI
Dectin-1 Signaling Mechanisms$533,266
R01 · FY2023 · AI · contact PI
Targeting the Mycobiome in Genetically Defined Patients with Crohns Disease$640,531
R01 · FY2022 · DK · contact PI
Dectin-1 Signaling Mechanisms$533,266
R01 · FY2022 · AI · contact PI
Targeting the Mycobiome in Genetically Defined Patients with Crohns Disease$691,474
R01 · FY2021 · DK · contact PI
Generating protective immunity to Staphylococcus aureus$574,032
R01 · FY2021 · AI · contact PI
Dectin-1 Signaling Mechanisms$533,266
R01 · FY2021 · AI · contact PI
Host immunity to commensal gut fungi$479,837
R01 · FY2021 · DK · contact PI
Developing a MRI-guided Disease-Modifying Therapy for Post Infarction Chronic Heart Failure$867,419
R01 · FY2020 · HL · contact PI
Generating protective immunity to Staphylococcus aureus$581,032
R01 · FY2020 · AI · contact PI
Dectin-1 Signaling Mechanisms$533,266
R01 · FY2020 · AI · contact PI
Host immunity to commensal gut fungi$479,837
R01 · FY2020 · DK · contact PI
Pr 4: Immune Responses to Fungi Associated with Crohn's Disease.$435,406
P01 · FY2020 · DK · contact PI
Innate Recognition of Bacterial Sugars$350,000
R01 · FY2020 · GM · contact PI
Antifungal immunity in Hirschsprung-Associated Enterocolitis$255,000
R21 · FY2020 · AI · contact PI
Developing a MRI-guided Disease-Modifying Therapy for Post Infarction Chronic Heart Failure$867,246
R01 · FY2019 · HL
Generating protective immunity to Staphylococcus aureus$550,625
R01 · FY2019 · AI · contact PI
Dectin-1 Signaling Mechanisms$533,266
R01 · FY2019 · AI · contact PI
Host immunity to commensal gut fungi$479,837
R01 · FY2019 · DK · contact PI
Pr 4: Immune Responses to Fungi Associated with Crohn's Disease.$449,359
P01 · FY2019 · DK · contact PI
Innate Recognition of Bacterial Sugars$350,000
R01 · FY2019 · GM · contact PI
Antifungal immunity in Hirschsprung-Associated Enterocolitis$212,500
R21 · FY2019 · AI · contact PI
Developing a MRI-guided Disease-Modifying Therapy for Post Infarction Chronic Heart Failure$867,048
R01 · FY2018 · HL
Generating protective immunity to Staphylococcus aureus$560,600
R01 · FY2018 · AI · contact PI
Host immunity to commensal gut fungi$476,777
R01 · FY2018 · DK · contact PI
Pr 4: Immune Responses to Fungi Associated with Crohn's Disease.$456,606
P01 · FY2018 · DK · contact PI
Innate Recognition of Bacterial Sugars$350,000
R01 · FY2018 · GM · contact PI
Developing a MRI-guided Disease-Modifying Therapy for Post Infarction Chronic Heart Failure$907,563
R01 · FY2017 · HL
Generating protective immunity to Staphylococcus aureus$570,400
R01 · FY2017 · AI · contact PI
Dectin-1 Signaling Mechanisms$425,000
R01 · FY2017 · AI · contact PI
Pr 4: Immune Responses to Fungi Associated with Crohn's Disease.$412,773
P01 · FY2017 · DK · contact PI
Innate Recognition of Bacterial Sugars$350,000
R01 · FY2017 · GM · contact PI
Dectin-1 Signaling Mechanisms$425,000
R01 · FY2016 · AI · contact PI
Pr 4: Immune Responses to Fungi Associated with Crohn's Disease.$419,079
P01 · FY2016 · DK · contact PI
Host immunity to commensal gut fungi$441,774
R01 · FY2015 · DK · contact PI
Dectin-1 Signaling Mechanisms$425,000
R01 · FY2015 · AI · contact PI
Innate Immune Sensing of Bacterial Sugars$330,000
R01 · FY2015 · GM · contact PI
Measuring Phagosomal Temperatures$208,750
R21 · FY2015 · AI · contact PI
Host immunity to commensal gut fungi$438,903
R01 · FY2014 · DK · contact PI
Dectin-1 Signaling Mechanisms$425,000
R01 · FY2014 · AI · contact PI
Innate Immune Sensing of Bacterial Sugars$330,000
R01 · FY2014 · GM · contact PI
Measuring Phagosomal Temperatures$213,650
R21 · FY2014 · AI · contact PI
Host immunity to commensal gut fungi$431,160
R01 · FY2013 · DK · contact PI
Innate Immune Sensing of Bacterial Sugars$318,450
R01 · FY2013 · GM · contact PI
Impact of Antibiotics and PBP2a on the Immunopathology of MRSA pneumonia$232,650
R21 · FY2013 · AI
Host immunity to commensal gut fungi$451,823
R01 · FY2012 · DK · contact PI
Non-Toll-like receptor innate immune signaling$389,590
R01 · FY2012 · AI · contact PI
Innate Immune Sensing of Bacterial Sugars$330,000
R01 · FY2012 · GM · contact PI
Impact of Antibiotics and PBP2a on the Immunopathology of MRSA pneumonia$206,250
R21 · FY2012 · AI
Non-Toll-like receptor innate immune signaling$389,590
R01 · FY2011 · AI · contact PI
Phagosomal targeting of CARD proteins$319,172
R01 · FY2011 · GM · contact PI
Non-Toll-like receptor innate immune signaling$393,525
R01 · FY2010 · AI · contact PI
Phagosomal targeting of CARD proteins$324,546
R01 · FY2010 · GM · contact PI
Phagosomal targeting of CARD proteins$48,256
R01 · FY2010 · GM · contact PI
Non-Toll-like receptor innate immune signaling$397,500
R01 · FY2009 · AI · contact PI
Phagosomal targeting of CARD proteins$330,951
R01 · FY2009 · GM · contact PI
Non-Toll-like receptor innate immune signaling$397,500
R01 · FY2008 · AI · contact PI
Phagosomal targeting of CARD proteins$330,809
R01 · FY2008 · GM · contact PI
TOLL-LIKE RECEPTORS: ACTIVATORS OF INNATE IMMUNITY$208,547
R01 · FY2005 · GM
TOLL-LIKE RECEPTORS: ACTIVATORS OF INNATE IMMUNITY$72,716
R01 · FY2005 · GM
TOLL-LIKE RECEPTORS: ACTIVATORS OF INNATE IMMUNITY$302,861
R01 · FY2004 · GM
TOLL-LIKE RECEPTORS: ACTIVATORS OF INNATE IMMUNITY$303,011
R01 · FY2003 · GM
TOLL-LIKE RECEPTORS: ACTIVATORS OF INNATE IMMUNITY$303,156
R01 · FY2002 · GM
ANALYSIS OF TOLL LIKE RECEPTOR SIGNALING COMPLEXES$0
U54 · FY2002 · AI
TOLL-LIKE RECEPTORS: ACTIVATORS OF INNATE IMMUNITY$303,297
R01 · FY2001 · GM